StreetAlpha
RenovoRx, Inc. · SEC Form 4

RNXT Insider Trading

From SEC Form 421 trades in 2 yearsUpdated Nov 19, 2026

Every open market buy and sale of RenovoRx, Inc. stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are buying over the last 12 months: $131K bought and $0 sold.

← RNXT stock page

Insiders are buying
Bought, 12 months$131K10 buys · 3 insiders
Sold, 12 months$00 sales · 0 insiders
Net+$131Kbought minus sold
Planned sales–of sold value, 10b5-1 plans

Buying and selling by month

open market, last 12 months
2025-12: bought $37KDec2026-01: bought $10KJanFebMarApr2026-05: bought $20KMayJunJulAugSepOct2026-11: bought $46KNov
Bought (up)Sold (down)
AI Pro · insider alerts

Get an alert when RNXT insiders trade

We read every Form 4 the moment the SEC posts it and tell you when an RNXT officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.

Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.

Every RNXT insider trade

2 years · newest first
InsiderTypePriceHeld afterFiled
Nov 16, 2026Ramtin AgahExecutive Chairman and CMOBuy50,000$0.93$46K848,460Nov 17Form 4
May 19, 2026Mark VollCFOBuy25,000$0.79$20K142,380May 21Form 4
Jan 21, 2026Ramtin AgahChief Medical OfficerBuy10,000$1.00$10K798,460Jan 22Form 4
Dec 31, 2025Ramtin AgahChief Medical OfficerBuy9,795$0.86$8K788,460Jan 5Form 4
Dec 30, 2025Ramtin AgahChief Medical OfficerBuy205$0.83$170778,665Jan 2Form 4
Dec 18, 2025Shaun BagaiCEOBuy5,000$0.90$5K340,040Dec 22Form 4
Dec 17, 2025Shaun BagaiCEOBuy5,000$0.85$4K335,040Dec 19Form 4
Dec 16, 2025Ramtin AgahChief Medical OfficerBuy12,000$0.85$10K778,460Dec 17Form 4
Dec 5, 2025Ramtin AgahChief Medical OfficerBuy10,000$0.96$10K766,460Dec 8Form 4
Nov 24, 2025Ramtin AgahChief Medical OfficerBuy22,000$0.80$18K756,460Nov 24Form 4
Aug 25, 2025Shaun BagaiCEOBuy10,000$0.93$9K330,040Aug 26Form 4
Jun 5, 2025Ramtin AgahChief Medical OfficerBuy21,000$1.40$29K734,460Jun 9Form 4
Apr 15, 2025Ramtin AgahChief Medical OfficerBuy15,000$0.90$14K1,113,460Apr 17Form 4
Apr 15, 2025Shaun BagaiCEOBuy7,500$0.91$7K320,040Apr 16Form 4
Apr 11, 2025Ramtin AgahChief Medical OfficerBuy20,000$0.80$16K1,098,460Apr 14Form 4
🔒 6 more trades. Create a free account or sign in to see them all.

RNXT insider trading FAQ

Are RNXT insiders buying or selling?

Insiders are buying over the last 12 months. 3 insiders bought $131K of RNXT on the open market in 10 trades, and 0 sold $0 in 0 trades.

When did an RNXT insider last buy shares?

Ramtin Agah (Executive Chairman and CMO) bought 50,000 shares for $46K on Nov 16, 2026, reported on Nov 17, 2026.

When did an RNXT insider last sell shares?

There has been no open market insider sale of RNXT in the last two years.

What is a Form 4?

Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.

Why do insider sales matter less than buys?

Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.

From SEC Form 4 filings · Not investment advice